Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation

Clinical trial NCT02565693 · COMPLETED

Trial details

NCT number: NCT02565693
Sponsor: UMC Utrecht
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cerebral Hemorrhage Atrial Fibrillation

Start date: 2014-09-01
Primary completion: 2021-01-31
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.